Pulike Biological Engineering, Inc. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 507.79 million compared to CNY 574.31 million a year ago. Revenue was CNY 512.71 million compared to CNY 579.23 million a year ago. Net income was CNY 80.26 million compared to CNY 163.6 million a year ago. Basic earnings per share from continuing operations was CNY 0.26 compared to CNY 0.52 a year ago. Diluted earnings per share from continuing operations was CNY 0.26 compared to CNY 0.52 a year ago.